HWN Suggests

Systemic Mastocytosis: Understanding Mast Cell Activation and Its Impact

For many, the trouble begins with a collection of confusing symptoms—unpredictable allergic-like reactions, persistent bone pain, stomach issues, and a deep fatigue that never seems to go away. If this sounds familiar, you may be on what many call a "diagnostic odyssey," searching for answers that tie these seemingly unrelated problems together. One possible, though uncommon, answer is systemic mastocytosis, a condition caused by the body's mast cell. Understanding this complex rare disorder is the first step toward managing its symptoms and improving your quality of life.

read full article

Featured

 Systemic Mastocytosis

The exact prevalence of systemic mastocytosis is challenging to determine due to its rarity and often varied presentation, but it is estimated to affect approximately 1 in 10,000 to 50,000 people globally, with figures varying based on diagnostic criteria and population studies (Source: World Health Organization classification of tumors of hematopoietic and lymphoid tissues). The disease can affect individuals of any age, though adult-onset forms are more common and often more indolent, while pediatric cases can sometimes resolve spontaneously or present with more aggressive features.

 Systemic mastocytosis: current status and challenges in 2024

Oncologists, hematologists, allergists, gastroenterologists, endocrinologists, dermatologists, and hematopathologists in the community and in academia have made significant strides in SM. Many patients with AdvSM can achieve long-term, progression-free phases with TKI therapy, chemotherapy, or allo-HCT.

Articles of Interest

Types of Systemic Mastocytosis and Treatments

There are several types of Systemic Mastocytosis. They differ in how many mast cells build up, where they build up in the various parts of the body, and the types of symptoms that may be experienced. Importantly, all must satisfy the specific diagnostic criteria for Systemic Mastocytosis...

MASTering systemic mastocytosis: Lessons learned from a large patient cohort

Systemic mastocytosis (SM), a rare condition affecting about 32,000 individuals in the United States, is often misdiagnosed or underdiagnosed owing to its nonspecific symptoms and the need for invasive biopsies.

Review and Updates on Systemic Mastocytosis and Related Entities

The diagnosis of SM requires the integration of bone marrow morphologic, immunophenotypic, and molecular findings, as well as clinical signs and symptoms. Moreover, understanding the wide range of clinical presentations for patients with mast cell disorders is necessary for accurate and timely diagnosis.

SMthing About Systemic Mastocytosis

SM is the buildup of abnormal mast cells in different parts of the body such as the skin, liver, spleen, bone marrow, and digestive tract that can cause a variety of symptoms such as rashes, bone pain, and diarrhea. In advanced cases, mast cells can also cause organ damage. While these symptoms can often be associated with other conditions, the combination of multiple symptoms in different parts of the body is common among people with SM. In approximately 95% of cases, SM occurs due to a genetic mutation in the gene called KIT D816V.

Resources

It's SM Thing

Getting an SM diagnosis can be a complicated process. Since there are so many different symptoms, it can be tough to connect the pieces of the puzzle.

SuspectSM

Recognizing the symptoms is just the beginning. Systemic mastocytosis (SM) can deal patients a range of unpredictable and debilitating symptoms that affect multiple organ systems—such as skin lesions, anaphylaxis, diarrhea, and sometimes organ damage

Clinical Trials

Ongoing SM Trials...

HUB

Mast cell activation syndrome and systemic mastocytosis present the same signs and symptoms. In the case of mast cell activation syndrome there is no build up of mast cells in the bone marrow. Systemic mastocytosis is also characterised by the presence of a mutation of the c-KIT gene. This mutation is not generally hereditary.

StatPearls

Systemic mastocytosis is an aggressive disorder characterized by the release of numerous vasoactive cell mediators due to excessive activity of mast cells, which results in a wide variety of symptoms. Symptoms include anaphylaxis, flushing, nonspecific GI as well as neuropsychiatric complaints.